NAFLD

https://pubmed.ncbi.nlm.nih.gov/33248976/ NAFLD

Arab J Gastroenterol. 2020 Nov 25;S1687-1979(20)30108-8.
doi: 10.1016/j.ajg.2020.09.003.Online ahead of print.

Association of obesity and non-alcoholic fatty liver disease with the fecal calprotectin level in children

Fatma Demirbaş 1, Gönül Çaltepe 2, Atakan Comba 2, Hasan Abbasguliyev 2, Neval Yurttan Uyar 3, Ayhan Gazi Kalaycı 2

Abstract

Background and study aims: As the prevalence of obesity increased, obesity-related comorbidities such as non-alcoholic fatty liver disease (NAFLD) also increased. The aim of this study is to investigate the presence of intestinal inflammation by evaluating the faecal calprotectin (FC) level in children with obesity and NAFLD and to determine the factors affecting the FC level.

Published on: 
Nov-2020

https://pubmed.ncbi.nlm.nih.gov/38523838/ cholecystitis

Front Pediatr. 2024 Mar 8:12:1339920.
doi: 10.3389/fped.2024.1339920. eCollection 2024.

Clinical analysis of infectious mononucleosis complicated with acute acalculous cholecystitis

Caijie Gao 1, Liming Cao 1, Xiaoli Mei 1
Affiliations expand
PMID: 38523838

PMCID: PMC10957744

DOI: 10.3389/fped.2024.1339920
Abstract

Objective: This study aimed to investigate specific clinical diagnostic methods for children with infectious mononucleosis (IM) complicated by acute acalculous cholecystitis (AAC).

Published on: 
Mar-2024

https://pubmed.ncbi.nlm.nih.gov/36980118/ NAFLD
Children (Basel). 2023 Mar 16;10(3):560.
doi: 10.3390/children10030560.

Comparison of MAFLD and NAFLD Characteristics in Children

Yunfei Xing 1, Jiangao Fan 2, Hai-Jun Wang 1, Hui Wang 1

Abstract
Background & aims: An international panel proposed a diagnostic framework for metabolic-associated fatty liver disease (MAFLD) in children. The aim was to compare the clinical features of MAFLD and nonalcoholic fatty liver disease (NAFLD) in children.

Methods: The characteristic differences between NAFLD and MAFLD in children were compared with the National Health and Nutrition Examination Survey (NHANES) 2017-2018 in the U.S. and the Comprehensive Prevention Project for Overweight and Obese Adolescents (CPOOA) study in China.

Published on: 
Mar-2023

https://pubmed.ncbi.nlm.nih.gov/38388968/ NAFLD

World J Pediatr. 2024 Feb 22.
doi: 10.1007/s12519-023-00789-5. Online ahead of print.

Continuous age- and sex-specific reference ranges of liver enzymes in Chinese children and application in pediatric non-alcoholic fatty liver disease

Zhao-Yuan Wu 1, Si-Wei Chi 1, Liu-Jian Ouyang 1, Xiao-Qin Xu 1, Jing-Nan Chen 1, Bing-Han Jin 1, Rahim Ullah 1, Xue-Lian Zhou 1, Ke Huang 1, Guan-Ping Dong 1, Zhe-Ming Li 2, Ying Shen 3, Jie Shao 3, Yan Ni 1, Jun-Fen Fu 4, Qiang Shu 5, Wei Wu 6

Abstract

Published on: 
Feb-2024

https://pubmed.ncbi.nlm.nih.gov/38623922/ NAFLD

J Pediatr Gastroenterol Nutr. 2024 Apr 16.
doi: 10.1002/jpn3.12218. Online ahead of print.

Correlating neighborhood-level deprivation and pediatric metabolic dysfunction-associated steatotic liver disease

Nicole E Hickman 1 2, Mason Price 1, Noe C Crespo 3, Ariel E Feldstein 4 5
Affiliations expand
PMID: 38623922

DOI: 10.1002/jpn3.12218
Abstract

Objectives: The primary objective of this study is to further explore associations between social influencers of health and markers of disease severity at the time of presentation of patients with pediatric metabolic dysfunction-associated steatotic liver disease (MASLD) using neighborhood-level Area Deprivation Index (ADI) scores.

Published on: 
Apr-2024

https://pubmed.ncbi.nlm.nih.gov/36133310/ NAFLD

Front Endocrinol (Lausanne). 2022 Sep 5;13:1004128.
doi: 10.3389/fendo.2022.1004128.eCollection 2022.

Determinants of hyperglucagonemia in pediatric non-alcoholic fatty liver disease

Katharina Maruszczak 1, Konrad Radzikowski 1, Sebastian Schütz 2, Harald Mangge 3, Peter Bergsten 4, Anders Forslund 5, Hannes Manell 5, Thomas Pixner 6, Håkan Ahlström 7, Joel Kullberg 7, Katharina Mörwald 1, Daniel Weghuber 1
Affiliations expand
PMID: 36133310

PMCID: PMC9483010

DOI: 10.3389/fendo.2022.1004128
Free PMC article

Abstract

Published on: 
Sep-2022

https://pubmed.ncbi.nlm.nih.gov/37870272/ NAFLD

Hepatology. 2023 Oct 23.
doi: 10.1097/HEP.0000000000000644. Online ahead of print.

Development of Fibro-PeN, a clinical prediction model for moderate to severe fibrosis in children with nonalcoholic fatty liver disease

Andrew Wang 1 2, Amanda L Blackford 3, Cynthia Behling 1, Laura A Wilson 4, Kimberly P Newton 1 2, Stavra A Xanthakos 5, Mark H Fishbein 6, Miriam B Vos 7, Marialena Mouzaki 8, Jean P Molleston 9, Ajay K Jain 10, Paula Hertel 11, Kathryn Harlow Adams 9, Jeffrey B Schwimmer 1 2; NASH CRN

Published on: 
Oct-2023

https://pubmed.ncbi.nlm.nih.gov/38519764/ NAFLD

Review

Endocrine. 2024 Mar 22.
doi: 10.1007/s12020-024-03783-7. Online ahead of print.

Diet, exercise, and supplements: what is their role in the management of the metabolic dysfunction-associated steatotic liver disease in children?

Anastasios Serbis 1, Stergios A Polyzos 2, Stavroula A Paschou 3, Ekaterini Siomou 4, Dimitrios N Kiortsis 5
Affiliations expand
PMID: 38519764

DOI: 10.1007/s12020-024-03783-7
Abstract

Published on: 
Mar-2024

https://pubmed.ncbi.nlm.nih.gov/38004223/ NAFLD

Review

Nutrients. 2023 Nov 18;15(22):4829.
doi: 10.3390/nu15224829.

Dietary and Nutritional Interventions in Nonalcoholic Fatty Liver Disease in Pediatrics

Camila Farías 1, Camila Cisternas 1, Juan Cristobal Gana 2, Gigliola Alberti 2, Francisca Echeverría 3, Luis A Videla 4, Lorena Mercado 1, Yasna Muñoz 1 5, Rodrigo Valenzuela 2

Abstract

Published on: 
Nov-2023

https://pubmed.ncbi.nlm.nih.gov/34568090/ NAFLD

Front Cell Infect Microbiol. 2021 Sep 9;11:698852.
doi: 10.3389/fcimb.2021.698852.eCollection 2021.

Disease-Associated Gut Microbiota Reduces the Profile of Secondary Bile Acids in Pediatric Nonalcoholic Fatty Liver Disease

Jiake Yu 1, Hu Zhang 1, Liya Chen 1, Yufei Ruan 1, Yiping Chen 1, Qi Liu 1

Abstract

Published on: 
Sep-2021

CLF Intro movie

Financial Aid Offered by Trusts

Follow us on: